Dipeptidyl peptidase-IV and related molecules: markers of malignancy? (Q38089765)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

title

Dipeptidyl peptidase-IV and related molecules: markers of malignancy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

Jonathan S Duke-Cohan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

1

Aleksi Sedo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Jarmila Stremenová

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

English

0 references

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

Expert Opinion on Medical Diagnostics

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

677-689

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Proline-dependent structural and biological properties of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The structure and function of CD26 in the T‐cell immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Transmembrane interaction mediates complex formation between peptidase homologues and Kv4 channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Direct association of adenosine deaminase with a T cell activation antigen, CD26

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The Simpson-Golabi-Behmel syndrome causative glypican-3, binds to and inhibits the dipeptidyl peptidase activity of CD26

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Does human attractin have DP4 activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Insights into how CUB domains can exert specific functions while sharing a common fold: conserved and specific features of the CUB1 domain contribute to the molecular basis of procollagen C-proteinase enhancer-1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The protease domain of procollagen C-proteinase (BMP1) lacks substrate selectivity, which is conferred by non-proteolytic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase II (DPPII), a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase II and leukocyte cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Modulation of Kv4.2 channel expression and gating by dipeptidyl peptidase 10 (DPP10)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV inhibitors and diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The cysteine-rich region of dipeptidyl peptidase IV (CD 26) is the collagen-binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Humanized anti-CD26 monoclonal antibody as a treatment for malignant mesothelioma tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Aminopeptidase M and dipeptidyl peptidase IV activity in epithelial skin tumors: a histochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

FAPalpha, a surface peptidase expressed during wound healing, is a tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

'Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Activation of EDTA-resistant gelatinases in malignant human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

glycylprolyl β-naphthylamidase activity in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Serum dipeptidyl peptidase activities as a possible marker of oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Purification, identification and characterisation of seprase from bovine serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Role of tumor markers in patients with solid cancers: A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Expression of dipeptidyl aminopeptidase IV activity in thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

Serum glycylproline dipeptidyl aminopeptidase activity in human hepatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/17530059.2.6.677

21 January 2018

Identifiers

DOI

10.1517/17530059.2.6.677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23495778 AND SRC:MED&resulttype=core&format=json

26 February 2020

1 reference